Intensity Therapeutics (INTS) executive compensation, 2026 proxy

Lewis H. Bender, President and Chief Executive Officer, was paid $1.4M in 2025, down 45% from $2.5M the year before.

Filed
April 30, 2026
Annual meeting
June 16, 2026
Pay year
2025
Named executives
3
CEO total pay
$1.4M-45% vs prior year
CEO 2025 Salary
$549,150Base salary for fiscal year
CFO 2025 Total Pay
$723,739Total compensation for Joseph Talamo
PAO 2025 Total Pay
$378,452Total compensation for John Wesolowski

How Bender was paid

$1.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary41%Bonus30%Option awards25%All other compensation4%

Named executive officers

ExecutiveTotal
Lewis H. BenderPresident and Chief Executive Officer$1,355,482
Joseph TalamoChief Financial Officer$723,739
John WesolowskiPrincipal Accounting Officer and Controller$378,452

What changed and why

  • $1.4MCEO total compensation decreased to $1,355,482 in 2025 from $2,486,169 in 2024.
  • $340KOption awards for the CEO totaled $340,138 down from $1,889,162 in the prior year.
  • 56%Bonus compensation of $411,863 was awarded to the CEO for 2025, with 56% payable in common stock.
  • $43,831All other compensation for the CEO included $43,831 for health and dental insurance and $10,500 in 401(k) matching.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.